| Size | Price | Stock |
|---|---|---|
| 1mg | $25 | In-stock |
| 5mg | $45 | In-stock |
| 10mg | $63 | In-stock |
| 50 mg | Get quote | |
| 100 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-121944 |
| M.Wt: | 164.16 |
| Formula: | C8H8N2O2 |
| Purity: | >98 % |
| Solubility: | DMSO : 100 mg/mL (ultrasonic) |
Ricinine is a central nervous system stimulant found in Ricinus communis. Ricinine binds near the benzodiazepine site of the GABAA receptor, reducing benzodiazepine binding affinity through an allosteric effect, and shows no interaction with AMPA, 5-HT1A, muscarinic receptors, or α1 adrenergic receptors. Ricinine improves memory consolidation in mice at low doses, while at high doses it induces seizures, an effect that is selectively inhibited by diazepam. Ricinine shortens the lifespan of Anopheles mosquitoes through sugar feeding and promotes the development of Plasmodium falciparum in mosquitoes. Ricinine is used in research related to epilepsy, amnesia, and malaria[1][2][3].
In Vitro:Ricinine (30-100 μM; 60 min) selectively decreases the binding of [3H]-flunitrazepam to central benzodiazepine receptors in rat cerebral cortical membranes in a concentration-dependent manner, without affecting its binding to GABAA, AMPA, 5-HT1A, ω1-benzodiazepine, muscarinic, or α1-adrenergic receptors[1].
Ricinine (2-4 mM) increases state IV respiration in isolated rat liver mitochondria and decreases the respiratory control ratio at high concentrations[1].
In Vivo:Ricinine (10-40 mg/kg; subcutaneous injection; single dose) induces dose-dependent convulsive seizures in Swiss mice at doses of 20 mg/kg and above, with consistent behavioral and electroencephalographic progression[1].
Ricinine (10-40 mg/kg; subcutaneous injection; single dose; administered 30 min after intraperitoneal pretreatment) induces clonic seizures in mice with a control ED50 of 27.5 mg/kg, which is selectively inhibited by Diazepam but not by Phenobarbital, Phenytoin (HY-B0448), or Ethosuximide (HY-B1378)[1].
Ricinine (10-40 mg/kg; subcutaneous injection; single dose) produces dose-dependent central nervous system excitation in mice, including exophthalmos, mydriasis, enhanced sensorimotor reactivity, and clonic seizures, with an LD50 of 25 mg/kg[2].
Ricinine (0.1-25 mg/kg; i.p./s.c.; single dose) does not produce anxiogenic, neuroleptic-like, or locomotor-altering effects in mice at high doses[2].
Ricinine (0.08-0.15 mg/kg; subcutaneous injection; administered immediately after training; single dose) improves memory consolidation in the passive avoidance task in mice, exhibiting an inverted U-shaped dose-response relationship[2].
Ricinine (0.04-0.08 g/l; oral; continuous administration before and after infection; feeding pads replaced daily until death) accelerates parasite development in both P. falciparum-infected An. coluzzii and An. gambiae, and shortens the median survival time of mosquitoes by 3.5 days, with no effect on the overall infection rate of An. coluzzii, but increases the infection rate of An. gambiae by 14%[3].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.